Literature DB >> 9759656

Identification of a lipocalin in mucosal glands of the human tracheobronchial tree and its enhanced secretion in cystic fibrosis.

B Redl1, P Wojnar, H Ellemunter, H Feichtinger.   

Abstract

Members of the lipocalin protein family are characterized by their ability to bind small hydrophobic molecules. Some of them are known to be produced by various glands and secretory cells. Under certain conditions, these proteins would be ideally suited for clearance of lipophilic, potentially harmful substances and might also act as protection factors in airway secretions. We therefore used RT-PCR analysis with a set of oligonucleotide primers deduced from conserved regions of lipocalin members to identify specific RNA isolated from human trachea. With two of these oligonucleotide primers, a positive result was obtained. Sequencing of the RT-PCR products revealed that the DNA fragments were identical to the lipocalin 1 (LCN1) encoding cDNA. LCN1 is an unusual lipocalin member that binds a variety of lipophilic compounds and exhibits cysteine proteinase inhibitor and antimicrobial activities. The local production and topographic distribution of LCN1 in the human tracheobronchial tree was then investigated by immunoperoxidase staining on thin-layer sections using a specific antiserum. LCN1 was detectable in the acini of serous mucosal glands and sometimes within the glandular lumen, suggesting excretion of the protein. The latter finding was tested and verified by Western blot analysis of bronchial secretions of healthy individuals. Furthermore, the results of SDS-PAGE and Western blot analysis of bronchial secretions from patients with cystic fibrosis (CF), which are usually characterized by an increase of airway lipids, suggested that LCN1 secretion was enhanced. Northern blot analysis of RNA from normal trachea and RNA isolated from tracheal biopsies of patients with CF indicated that induced secretion was due to an up-regulated expression of the LCN1 gene. Thus, our investigations present the first clear evidence that LCN1 is induced in infection or inflammation and support the idea that this lipocalin functions as a physiologic protection factor of epithelia in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759656

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

Review 1.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

2.  Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease.

Authors:  Benjamin L Nicholas; Paul Skipp; Sheila Barton; Dave Singh; Dinesh Bagmane; Richard Mould; Gilbert Angco; Jon Ward; Binita Guha-Niyogi; Susan Wilson; Peter Howarth; Donna E Davies; Stephen Rennard; C David O'Connor; Ratko Djukanovic
Journal:  Am J Respir Crit Care Med       Date:  2010-01-28       Impact factor: 21.405

3.  Human tear lipocalin acts as an oxidative-stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system.

Authors:  M Lechner; P Wojnar; B Redl
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.

Authors:  Maria Fluckinger; Hubertus Haas; Petra Merschak; Ben J Glasgow; Bernhard Redl
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.

Authors:  Xiao-ru Wang; Yong-pu Li; Shui Gao; Wei Xia; Kun Gao; Qing-hua Kong; Hui Qi; Ling Wu; Jing Zhang; Jie-ming Qu; Chun-xue Bai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-27

6.  Pulse of inflammatory proteins in the pregnant uterus of European polecats (Mustela putorius) leading to the time of implantation.

Authors:  Heli Lindeberg; Richard J S Burchmore; Malcolm W Kennedy
Journal:  R Soc Open Sci       Date:  2017-03-22       Impact factor: 2.963

7.  Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.

Authors:  Cecilia Veraar; Jonathan Kliman; Alberto Benazzo; Felicitas Oberndorfer; Maria Laggner; Philipp Hacker; Thomas Raunegger; Stefan Janik; Peter Jaksch; Walter Klepetko; Hendrik J Ankersmit; Bernhard Moser
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

8.  Tear Lipocalin and Lipocalin-Interacting Membrane Receptor.

Authors:  Ben J Glasgow
Journal:  Front Physiol       Date:  2021-08-19       Impact factor: 4.566

9.  Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.

Authors:  Jessica R Sheldon; Lauren E Himmel; Dillon E Kunkle; Andrew J Monteith; K Nichole Maloney; Eric P Skaar
Journal:  PLoS Pathog       Date:  2022-09-02       Impact factor: 7.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.